Press Releases

Oasmia Pharmaceutical AB (publ) announces result of the rights issue

The subscription period for Oasmia Pharmaceutical AB’s (publ) (“Oasmia” or the “Company”) rights issue ended on July 5, 2017. The result of the rights issue shows that 23,517,699 shares, rep...

The Oasmia Pharmaceutical Annual Report is now published

The Oasmia Annual Report for the fiscal year 2016/2017 is now available at the company website www.oasmia.com.

Issuance of warrants in Oasmia Pharmaceutical AB (publ)

Oasmia Pharmaceutical AB (publ) (the ”Company”) resolved, at the Extraordinary General Meeting of the Company on 2 June 2017, to establish two warrant programmes, series 2017:1 and series 2017:2, ...

Oasmia Pharmaceutical AB (publ) publishes prospectus by reason of the Rights Issue

The board of directors of Oasmia Pharmaceutical AB (publ) (”Oasmia”, ”Company” or “Group”) has prepared a prospectus (“Prospectus”) concerning the new issue of shares with preferential...

Oasmia Pharmaceutical enters into new exclusive marketing and distribution agreement concerning Russia and other CIS markets

Oasmia replaces previous distribution agreement with Hetero Group, a global group of Companies, representing a large operation with expanding capabilities

Oasmia Pharmaceutical AB (publ): The board of directors resolves upon a rights issue of approximately 163.9 MSEK

The board of directors of Oasmia Pharmaceutical AB (publ) (”Oasmia” or the ”Company”) announces that the board of directors on 11 June 2017 has resolved to, based on an authorisation from the ...

Oasmia Pharmaceutical AB (publ) replaces current convertible loan with new debt

The board of directors in Oasmia Pharmaceutical AB (publ) (”Oasmia” or the ”Company”) announces that it has agreed with the holders of convertibles in Oasmia’s convertible loan programme 201...

Report from extra general meeting 2 June 2017

Oasmia Pharmaceutical AB (publ) registration number 556332-6676 held an extra general meeting on Friday, 2 June 2017. The main content of the resolutions is summarized below. More detailed informatio...

Number of shares and votes in Oasmia Pharmaceutical AB (publ)

As of May 31 2017, the total number of shares and votes in Oasmia Pharmaceutical AB (publ) (“Oasmia”) amounts to 126,098,166 shares and votes.